
### [NCIT:C2853](http://purl.obolibrary.org/obo/NCIT_C2853)
**Label:** Papillary Adenocarcinoma

**Subclasses:** [NCIT:C46095](http://purl.obolibrary.org/obo/NCIT_C46095) (Solid Variant Thyroid Gland Papillary Carcinoma), [NCIT:C7645](http://purl.obolibrary.org/obo/NCIT_C7645) (Intracystic Papillary Breast Carcinoma), [NCIT:C27254](http://purl.obolibrary.org/obo/NCIT_C27254) (Papillary Eccrine Carcinoma), [NCIT:C7427](http://purl.obolibrary.org/obo/NCIT_C7427) (Thyroid Gland Diffuse Sclerosing Papillary Carcinoma), [NCIT:C6975](http://purl.obolibrary.org/obo/NCIT_C6975) (Papillary Renal Cell Carcinoma), [NCIT:C27890](http://purl.obolibrary.org/obo/NCIT_C27890) (Sporadic Papillary Renal Cell Carcinoma), [NCIT:C27937](http://purl.obolibrary.org/obo/NCIT_C27937) (Thymic Papillary Adenocarcinoma), [NCIT:C8377](http://purl.obolibrary.org/obo/NCIT_C8377) (Papillary Serous Cystadenocarcinoma), [NCIT:C4035](http://purl.obolibrary.org/obo/NCIT_C4035) (Thyroid Gland Papillary Carcinoma), [NCIT:C6256](http://purl.obolibrary.org/obo/NCIT_C6256) (Ovarian Serous Surface Papillary Adenocarcinoma), [NCIT:C9222](http://purl.obolibrary.org/obo/NCIT_C9222) (Hereditary Papillary Renal Cell Carcinoma), [NCIT:C9122](http://purl.obolibrary.org/obo/NCIT_C9122) (Stage III Thyroid Gland Papillary Carcinoma), [NCIT:C36085](http://purl.obolibrary.org/obo/NCIT_C36085) (Invasive Papillary Breast Carcinoma), [NCIT:C95967](http://purl.obolibrary.org/obo/NCIT_C95967) (Ampulla of Vater Invasive Papillary Adenocarcinoma), [NCIT:C65204](http://purl.obolibrary.org/obo/NCIT_C65204) (Papillary Mucinous Cystadenocarcinoma), [NCIT:C39896](http://purl.obolibrary.org/obo/NCIT_C39896) (Prostate Ductal Adenocarcinoma, Papillary Pattern), [NCIT:C35558](http://purl.obolibrary.org/obo/NCIT_C35558) (Tall Cell Variant Thyroid Gland Papillary Carcinoma), [NCIT:C3777](http://purl.obolibrary.org/obo/NCIT_C3777) (Papillary Cystadenocarcinoma), [NCIT:C54400](http://purl.obolibrary.org/obo/NCIT_C54400) (Nasopharyngeal Papillary Adenocarcinoma), [NCIT:C7438](http://purl.obolibrary.org/obo/NCIT_C7438) (Infiltrating Papillary Adenocarcinoma), [NCIT:C46004](http://purl.obolibrary.org/obo/NCIT_C46004) (Thyroid Gland Papillary Microcarcinoma), [NCIT:C5650](http://purl.obolibrary.org/obo/NCIT_C5650) (Papillary Lung Adenocarcinoma), [NCIT:C7695](http://purl.obolibrary.org/obo/NCIT_C7695) (Primary Peritoneal Serous Papillary Adenocarcinoma), [NCIT:C6267](http://purl.obolibrary.org/obo/NCIT_C6267) (Fallopian Tube Papillary Adenocarcinoma), [NCIT:C9134](http://purl.obolibrary.org/obo/NCIT_C9134) (Papillary Breast Carcinoma), [NCIT:C4182](http://purl.obolibrary.org/obo/NCIT_C4182) (Serous Surface Papillary Carcinoma), [NCIT:C27886](http://purl.obolibrary.org/obo/NCIT_C27886) (Type 1 Papillary Renal Cell Carcinoma), [NCIT:C123903](http://purl.obolibrary.org/obo/NCIT_C123903) (Childhood Thyroid Gland Papillary Carcinoma), [NCIT:C5472](http://purl.obolibrary.org/obo/NCIT_C5472) (Gastric Papillary Adenocarcinoma), [NCIT:C27887](http://purl.obolibrary.org/obo/NCIT_C27887) (Type 2 Papillary Renal Cell Carcinoma), [NCIT:C4190](http://purl.obolibrary.org/obo/NCIT_C4190) (Intraductal Papillary Breast Carcinoma), [NCIT:C9082](http://purl.obolibrary.org/obo/NCIT_C9082) (Stage II Thyroid Gland Papillary Carcinoma), [NCIT:C9083](http://purl.obolibrary.org/obo/NCIT_C9083) (Stage IV Thyroid Gland Papillary Carcinoma), [NCIT:C9081](http://purl.obolibrary.org/obo/NCIT_C9081) (Stage I Thyroid Gland Papillary Carcinoma), [NCIT:C37304](http://purl.obolibrary.org/obo/NCIT_C37304) (Multicentric Thyroid Gland Papillary Carcinoma), 

**Class expressions from DL-Learner:**

- Thing 53.30%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) 38.30%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40160](http://purl.obolibrary.org/obo/NCIT_C40160) (t(7;17)(p15;q21)))) 38.30%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40156](http://purl.obolibrary.org/obo/NCIT_C40156) (Endometrial Undifferentiated Carcinoma))) 38.30%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40155](http://purl.obolibrary.org/obo/NCIT_C40155) (Endometrial Small Cell Carcinoma))) 38.30%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40154](http://purl.obolibrary.org/obo/NCIT_C40154) (Endometrial Transitional Cell Carcinoma))) 38.30%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40153](http://purl.obolibrary.org/obo/NCIT_C40153) (Endometrial Mixed Adenocarcinoma))) 38.30%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40152](http://purl.obolibrary.org/obo/NCIT_C40152) (Serous Endometrial Intraepithelial Carcinoma))) 38.30%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40151](http://purl.obolibrary.org/obo/NCIT_C40151) (Grade 3 Endometrial Mucinous Adenocarcinoma))) 38.30%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40150](http://purl.obolibrary.org/obo/NCIT_C40150) (Grade 2 Endometrial Mucinous Adenocarcinoma))) 38.30%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40149](http://purl.obolibrary.org/obo/NCIT_C40149) (Grade 1 Endometrial Mucinous Adenocarcinoma))) 38.30%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40148](http://purl.obolibrary.org/obo/NCIT_C40148) (Grade 3 Endometrial Endometrioid Adenocarcinoma))) 38.30%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40147](http://purl.obolibrary.org/obo/NCIT_C40147) (Grade 2 Endometrial Endometrioid Adenocarcinoma))) 38.30%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40146](http://purl.obolibrary.org/obo/NCIT_C40146) (Grade 1 Endometrial Endometrioid Adenocarcinoma))) 38.30%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40142](http://purl.obolibrary.org/obo/NCIT_C40142) (Uterine Ligament Papillary Cystadenoma Associated with von Hippel-Lindau Disease))) 38.30%


